Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  denosumab
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 20090482, NCI-2013-00401, NCT01345019
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 20120249, NCI-2014-01183, NCT01951586
Denosumab in Treating Patients with Breast Cancer and Bone Metastases
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0007, NCI-2014-01273, NCI-2014-01069, NCT01952054
Radium Ra 223 Dichloride, Hormone Therapy, and Denosumab in Treating Patients with Hormone-Positive, Bone-Dominant Metastatic Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0508, NCI-2015-00508, NCT02366130
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 and over
Trial IDs: 20062004, NCI-2009-01485, NCT00680992
Anakinra or Denosumab and Everolimus in Advanced Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2011-1043, NCI-2012-01156, NCT01624766
Denosumab in Treating Patients With Stage I-III Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 117527, NCI-2012-02802, NCT01545648
Start Over